Ameritas Investment Partners’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,148
Closed -$20.5K 3345
2025
Q1
$20.5K Hold
4,148
﹤0.01% 2546
2024
Q4
$12.2K Hold
4,148
﹤0.01% 2849
2024
Q3
$19.6K Hold
4,148
﹤0.01% 2671
2024
Q2
$16K Hold
4,148
﹤0.01% 2712
2024
Q1
$22.2K Hold
4,148
﹤0.01% 2525
2023
Q4
$17.7K Hold
4,148
﹤0.01% 2633
2023
Q3
$16.3K Hold
4,148
﹤0.01% 2631
2023
Q2
$42K Buy
4,148
+1,344
+48% +$14.2K ﹤0.01% 2149
2023
Q1
$28.6K Hold
2,804
﹤0.01% 2308
2022
Q4
$32K Hold
2,804
﹤0.01% 2324
2022
Q3
$40K Hold
2,804
﹤0.01% 2146
2022
Q2
$37K Buy
2,804
+1,039
+59% +$14.2K ﹤0.01% 2197
2022
Q1
$30K Hold
1,765
﹤0.01% 2371
2021
Q4
$45K Buy
+1,765
New +$55K ﹤0.01% 2194

Other funds holding TSVT

Ameritas Investment Partners's TSVT Position: Q2 2025 in Review

Ameritas Investment Partners sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 4,148 shares — an estimated $20.5K sold.

Ameritas Investment Partners first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $45K in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Ameritas Investment Partners reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 4,148 2seventy bio shares in Q2 2025, an estimated $20.5K.
  • Ameritas Investment Partners first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Ameritas Investment Partners's 2seventy bio position peaked at $45K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.